4D Molecular Therapeutics Statistics
Total Valuation
FDMT has a market cap or net worth of $1.27 billion. The enterprise value is $1.00 billion.
| Market Cap | 1.27B |
| Enterprise Value | 1.00B |
Important Dates
The next estimated earnings date is Wednesday, May 8, 2024, after market close.
| Earnings Date | May 8, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
FDMT has 51.16 million shares outstanding. The number of shares has increased by 20.95% in one year.
| Shares Outstanding | 51.16M |
| Shares Change (YoY) | +20.95% |
| Shares Change (QoQ) | +1.44% |
| Owned by Insiders (%) | 3.53% |
| Owned by Institutions (%) | 85.55% |
| Float | 31.64M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 61.63 |
| Forward PS | 403.90 |
| PB Ratio | 4.15 |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 48.43 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 15.65, with a Debt / Equity ratio of 0.05.
| Current Ratio | 15.65 |
| Quick Ratio | n/a |
| Debt / Equity | 0.05 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -34.10% and return on invested capital (ROIC) is -35.00%.
| Return on Equity (ROE) | -34.10% |
| Return on Assets (ROA) | -31.10% |
| Return on Capital (ROIC) | -35.00% |
| Revenue Per Employee | $140,973 |
| Profits Per Employee | -$685,966 |
| Employee Count | 147 |
| Asset Turnover | 0.06 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +42.74% in the last 52 weeks. The beta is 2.86, so FDMT's price volatility has been higher than the market average.
| Beta (1Y) | 2.86 |
| 52-Week Price Change | +42.74% |
| 50-Day Moving Average | 28.89 |
| 200-Day Moving Average | 19.02 |
| Relative Strength Index (RSI) | 35.89 |
| Average Volume (30 Days) | 1,233,264 |
Short Selling Information
The latest short interest is 9.32 million, so 18.21% of the outstanding shares have been sold short.
| Short Interest | 9.32M |
| Short Previous Month | 8.50M |
| Short % of Shares Out | 18.21% |
| Short % of Float | 29.45% |
| Short Ratio (days to cover) | 12.24 |
Income Statement
In the last 12 months, FDMT had revenue of $20.72 million and -$100.84 million in losses. Loss per share was -$2.58.
| Revenue | 20.72M |
| Gross Profit | 20.72M |
| Operating Income | -112.87M |
| Pretax Income | -100.84M |
| Net Income | -100.84M |
| EBITDA | -95.09M |
| EBIT | -100.84M |
| Loss Per Share | -$2.58 |
Balance Sheet
The company has $288.23 million in cash and $14.67 million in debt, giving a net cash position of $273.56 million or $5.35 per share.
| Cash & Cash Equivalents | 288.23M |
| Total Debt | 14.67M |
| Net Cash | 273.56M |
| Net Cash Per Share | $5.35 |
| Equity / Book Value | 307.83M |
| Book Value Per Share | 6.02 |
| Working Capital | 277.64M |
Cash Flow
In the last 12 months, operating cash flow was -$75.79 million and capital expenditures -$2.77 million, giving a free cash flow of -$78.56 million.
| Operating Cash Flow | -75.79M |
| Capital Expenditures | -2.77M |
| Free Cash Flow | -78.56M |
| FCF Per Share | -$2.01 |
Margins
Gross margin is 100.00%, with operating and profit margins of -544.65% and -486.59%.
| Gross Margin | 100.00% |
| Operating Margin | -544.65% |
| Pretax Margin | -486.59% |
| Profit Margin | -486.59% |
| EBITDA Margin | -458.85% |
| EBIT Margin | -486.59% |
| FCF Margin | -379.11% |
Dividends & Yields
FDMT does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -20.95% |
| Shareholder Yield | -20.95% |
| Earnings Yield | -7.90% |
| FCF Yield | -6.15% |
Analyst Forecast
The average price target for FDMT is $46.56, which is 87.89% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $46.56 |
| Price Target Difference | 87.89% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 9 |
| Revenue Growth Forecast (5Y) | 66.07% |
| EPS Growth Forecast (5Y) | -0.41% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
FDMT has an Altman Z-Score of 22.25 and a Piotroski F-Score of 4.
| Altman Z-Score | 22.25 |
| Piotroski F-Score | 4 |